-
ReportersNotebook — Chain Pharmacy, 10/15/12
SUPPLIER NEWS — The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said. The drug maker announced the approval of Aerospan (flunisolide HFA) inhalation aerosol as a maintenance treatment for asthma in patients ages 6 years and older. The drug maker plans to launch the drug in early 2013.
-
New products boast affordable indulgence
Manufacturers are striving to jazz up the bath and body segment with new, spa-inspired fragrances and formulations as sales show a ho-hum attitude among beauty shoppers.
According to data provided by SymphonyIRI Group, sales of bath fragrances/bubble bath rose about 3% for the 12 weeks ended Aug. 12 at food, drug and mass (excluding Walmart). During that same period, sales of body scrubbers/massagers declined 5%, as sales of liquid body wash also dropped about 5%.